Dagseting:
Þriðjudagur, 12. mars 2013
Fundur númer:
357
Fjöldi mála á fundi:
39
Heiti verkefnis:
Lyfjarannsóknin: A multicenter, single arm study of trastuzumab emtansine (T-DM1) in HER2 positive locally advanced or metastatic breast cancer patients who have received prior anti-HER2 and chemotherapy-based treatment
Ábyrgðarmaður:
Óskar Þór Jakobsson

